A case of ventricular fibrillation as a consequence of capecitabine-induced secondary QT prolongation: A case report

Capecitabine is an oral fluoropyrimidine which can prolong QT interval. However, there have been no reports that capecitabine induced ventricular fibrillation (VF) due to secondary QT prolongation in patients with no structural heart disease. A 39-year-old woman developed VF during the chemotherapy...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Cardiol Cases
Autores principales: Hayasaka, Kazuto, Takigawa, Masateru, Takahashi, Atsushi, Kuwahara, Taishi, Okubo, Kenji, Tanaka, Yasuaki, Misawa, Toru, Mizusawa, Masafumi, Yamakami, Yosuke, Kojima, Keisuke, Sagawa, Yuichiro, Hishikari, Keiichi, Yamao, Kazuya, Nakashima, Emiko, Nakajima, Jun, Kimura, Shigeki, Takagi, Katsumasa, Hikita, Hiroyuki, Isobe, Mitsuaki
Formato: Artigo
Lenguaje:Inglês
Publicado: Japanese College of Cardiology 2017
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6149258/
https://ncbi.nlm.nih.gov/pubmed/30279790
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jccase.2017.03.009
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares